Diagnostics company Guardant Health (NASDAQ:GH) announced better-than-expected revenue in Q3 CY2025, with sales up 38.5% year on year to $265.2 million. The company’s full-year revenue guidance of ...

Guardant Health › Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher on Thursday after the precision oncology company ...

Guardant Health posts strong Q3 results and lifts outlook. See insights on GH stock's growth, financials, and what’s driving ...

Q3 2025 Earnings Call Transcript October 30, 2025 Operator: Good afternoon. Thank you for attending the Guardant Health Q3 ...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This ...

Saskatchewan’s tech sector is outpacing Prairie provinces Alberta and Manitoba in employment growth, with an increase of ...

Medicare Part B data show that of the 20 CPT codes seeing the largest increase in payments from 2022 to 2024, all are for molecular- or sequencing-based tests.

Misunderstandings about who needs screening and how often may be why some women skip mammograms. Here are eight claims about ...

Called the RESULTS Act, the bill would use a third-party database to set Medicare payment rates and would delay price cuts and data reporting scheduled for 2026.